Healius | HLS - Ebit

Aktienkurs
0.57
Täglich Wechseln
0 0%
Monatlich
-16.79%
Jährlich
-57.30%
Q1 Prognose
0.56




Ebit Veränderung Datum
Alcidion AUD 2.2M 1.76M 2025-12
Ansell USD 146.5M 29.2M 2025-12
Cochlear AUD 261.1M 13.9M 2025-12
CSL USD 2.64B 116M 2025-12
Fisher Paykel Healthcare NZD 298.2M 2.8M 2025-12
Integral Diagnostics AUD 24.99M 5.08M 2024-06
Mayne Pharma AUD -16.2M 13.2M 2024-06
Nanosonics AUD 9.12M 422K 2025-12
Polynovo AUD 2.06M 1.18M 2025-12
Ramsay Health Care AUD 541.1M 20.7M 2025-12
ResMed USD 497.6M 35.25M 2025-12
Sigma Healthcare AUD 809K 13.76M 2024-12
Sonic Healthcare AUD 423.94M 80.3M 2024-12